Perrigo Shares Outstanding 2010-2025 | PRGO
Perrigo shares outstanding from 2010 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
| Perrigo Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 137 |
| 2023 | 135 |
| 2022 | 135 |
| 2021 | 134 |
| 2020 | 137 |
| 2019 | 137 |
| 2018 | 138 |
| 2017 | 143 |
| 2016 | 143 |
| 2015 | 146 |
| 2015 | 140 |
| 2014 | 116 |
| 2013 | 95 |
| 2012 | 94 |
| 2011 | 94 |
| 2010 | 93 |
| 2009 | 94 |
| Perrigo Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-03-31 | 138 |
| 2024-12-31 | 137 |
| 2024-09-30 | 138 |
| 2024-06-30 | 137 |
| 2024-03-31 | 138 |
| 2023-12-31 | 135 |
| 2023-09-30 | 137 |
| 2023-06-30 | 137 |
| 2023-03-31 | 135 |
| 2022-12-31 | 135 |
| 2022-09-30 | 135 |
| 2022-06-30 | 135 |
| 2022-03-31 | 134 |
| 2021-12-31 | 134 |
| 2021-09-30 | 134 |
| 2021-06-30 | 134 |
| 2021-03-31 | 135 |
| 2020-12-31 | 137 |
| 2020-09-30 | 138 |
| 2020-06-30 | 138 |
| 2020-03-31 | 137 |
| 2019-12-31 | 137 |
| 2019-09-30 | 137 |
| 2019-06-30 | 137 |
| 2019-03-31 | 136 |
| 2018-12-31 | 138 |
| 2018-09-30 | 137 |
| 2018-06-30 | 139 |
| 2018-03-31 | 141 |
| 2017-12-31 | 143 |
| 2017-09-30 | 142 |
| 2017-06-30 | 143 |
| 2017-03-31 | 144 |
| 2016-12-31 | 143 |
| 2016-09-30 | 143 |
| 2016-06-30 | 143 |
| 2016-03-31 | 143 |
| 2015-12-31 | 146 |
| 2015-09-30 | 147 |
| 2015-06-30 | 146 |
| 2015-03-31 | 141 |
| 2014-12-31 | 137 |
| 2014-09-30 | 134 |
| 2014-06-30 | |
| 2014-03-31 | 134 |
| 2013-12-31 | 99 |
| 2013-09-30 | 95 |
| 2013-06-30 | |
| 2013-03-31 | 95 |
| 2012-12-31 | 95 |
| 2012-09-30 | 94 |
| 2012-06-30 | |
| 2012-03-31 | 94 |
| 2011-12-31 | 94 |
| 2011-09-30 | 94 |
| 2011-06-30 | |
| 2011-03-31 | 94 |
| 2010-12-31 | 93 |
| 2010-09-30 | 93 |
| 2010-06-30 | |
| 2010-03-31 | 93 |
| 2009-12-31 | 93 |
| 2009-09-30 | 93 |
| 2009-06-30 | |
| 2009-03-31 | 93 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $3.770B | $4.373B |
| Perrigo Co. plc, with a diversified revenue stream, sells infant formulas for the store brand market, generic extended topical prescription (Rx) products and specialty pharmaceutical drugs. It's focusing on self-care products as part of its transformation into a self-care company from a healthcare company. The company divested its Rx segment to Altaris Capital Partners. The company completed its transformation to a consumer self-care company by reconfiguring the portfolio through the divestiture of RX business. Currently, the company has 2 reporting segments. Consumer Self Care Americas (CSCA): The segment comprises the U.S., Mexico and Canada CHC business, including OTC, contract manufacturing, infant formula and animal health categories. Consumer Self Care International?(CSCI): The segment comprises the branded consumer healthcare (BCH) segment mainly in Europe and the company's consumer-focused businesses in the UK and Australia. This segment includes UK liquids licensed products business. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $235.226B | 28.28 |
| Boston Scientific (BSX) | United States | $157.620B | 39.46 |
| Stryker (SYK) | United States | $148.687B | 31.09 |
| EssilorLuxottica (ESLOY) | France | $134.580B | 0.00 |
| Medtronic (MDT) | Ireland | $110.773B | 16.17 |
| Lonza Group Ag (LZAGY) | Switzerland | $50.060B | 0.00 |
| Haleon (HLN) | United Kingdom | $49.664B | 28.26 |
| ResMed (RMD) | United States | $36.384B | 27.33 |
| GE HealthCare Technologies (GEHC) | United States | $32.899B | 15.62 |
| Agilent Technologies (A) | United States | $32.353B | 21.37 |
| Terumo (TRUMY) | Japan | $27.583B | 35.83 |
| Insulet (PODD) | United States | $23.046B | 90.46 |
| Koninklijke Philips (PHG) | Netherlands | $22.521B | 16.19 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.865B | 12.12 |
| Baxter (BAX) | United States | $16.144B | 12.05 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $12.881B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.032B | 0.00 |
| Demant (WILYY) | Denmark | $8.231B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.723B | 23.40 |
| Lantheus Holdings (LNTH) | United States | $5.316B | 13.41 |
| Prestige Consumer Healthcare (PBH) | United States | $4.327B | 19.33 |
| Haemonetics (HAE) | United States | $3.462B | 15.08 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| ICU Medical (ICUI) | United States | $3.321B | 24.49 |
| Envista Holdings (NVST) | United States | $3.012B | 25.03 |
| QuidelOrtho (QDEL) | United States | $2.190B | 15.06 |
| GN Store Nord (GNNDY) | Denmark | $2.097B | 17.37 |
| LeMaitre Vascular (LMAT) | United States | $1.915B | 42.80 |
| AtriCure (ATRC) | United States | $1.686B | 0.00 |
| Neogen (NEOG) | United States | $1.346B | 17.22 |
| Kestra Medical Technologies (KMTS) | United States | $1.280B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.248B | 12.67 |
| Green Thumb Industries (GTBIF) | United States | $1.207B | 27.14 |
| BioLife Solutions (BLFS) | United States | $1.083B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.976B | 12.48 |
| InMode (INMD) | Israel | $0.933B | 9.40 |
| CeriBell (CBLL) | United States | $0.657B | 0.00 |
| Evolus (EOLS) | United States | $0.642B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.611B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.580B | 0.00 |
| Owens & Minor (OMI) | United States | $0.564B | 4.68 |
| Valneva SE (VALN) | France | $0.536B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.503B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.456B | 0.00 |
| Surmodics (SRDX) | United States | $0.424B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.358B | 0.00 |
| SNDL (SNDL) | Canada | $0.349B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.335B | 12.33 |
| Canopy Growth (CGC) | Canada | $0.325B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.300B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.300B | 53.40 |
| Sanara MedTech (SMTI) | United States | $0.276B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.269B | 22.67 |
| Verano Holdings (VRNOF) | United States | $0.262B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.257B | 0.00 |
| Cerus (CERS) | United States | $0.256B | 0.00 |
| ZimVie (ZIMV) | United States | $0.247B | 11.24 |
| Biote (BTMD) | United States | $0.218B | 6.12 |
| OraSure Technologies (OSUR) | United States | $0.209B | 0.00 |
| Brainsway (BWAY) | Israel | $0.202B | 53.45 |
| Quanterix (QTRX) | United States | $0.194B | 0.00 |
| Omeros (OMER) | United States | $0.193B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.176B | 14.34 |
| TriSalus Life Sciences (TLSI) | United States | $0.173B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.131B | 16.18 |
| Exagen (XGN) | United States | $0.127B | 0.00 |
| Jin Medical (ZJYL) | China | $0.124B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.123B | 0.00 |
| Agape ATP (ATPC) | $0.108B | 0.00 | |
| MacroGenics (MGNX) | United States | $0.099B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.092B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.088B | 0.00 |
| Fonar (FONR) | United States | $0.088B | 11.30 |
| Veru (VERU) | United States | $0.075B | 0.00 |
| Zynex (ZYXI) | United States | $0.075B | 0.00 |
| InterCure (INCR) | Israel | $0.073B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.066B | 0.00 |
| Apyx Medical (APYX) | United States | $0.056B | 0.00 |
| United Health Products (UEEC) | United States | $0.056B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.053B | 0.00 |
| ImmuCell (ICCC) | United States | $0.050B | 0.00 |
| United-Guardian (UG) | United States | $0.040B | 13.87 |
| Rockwell Medical (RMTI) | United States | $0.037B | 0.00 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Safety Shot (SHOT) | United States | $0.029B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 32.93 |
| Allurion Technologies (ALUR) | United States | $0.024B | 0.00 |
| INLIF (INLF) | $0.019B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.015B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.015B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.012B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.009B | 0.00 |
| Senestech (SNES) | United States | $0.005B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.004B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.004B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Acuren (TIC) | United States | $0.000B | 0.00 |